Baxter International is a healthcare company that focuses on developing and providing a wide range of medical products and services to enhance patient care. The company specializes in creating innovative therapies and solutions for various health conditions, including renal and hospital care. With a strong emphasis on sustainability and improving patient outcomes, Baxter manufactures essential medical devices, pharmaceuticals, and biotechnology products that support the treatment of chronic diseases and acute medical conditions. Their commitment to research and development drives advancements in healthcare technology, helping to meet the needs of healthcare professionals and patients worldwide. Read More
What Happened? Shares of healthcare company Baxter International (NYSE:BAX) fell 1% in the morning session after Citigroup downgraded the stock to Sell from ...
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Neogen (NASDAQ:NEOG) and its ...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including ...
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. A lack ...
Baxter International (NYSE:BAX) held its 2026 annual meeting of stockholders by webcast, with shareholders giving preliminary approval to all five proposals presented by the company, including the election of nine directors, executive compensation, auditor ratification, an amended incentive plan and
Baxter’s first quarter results received a positive market reaction, reflecting management’s progress on its turnaround strategy despite ongoing operational a...
What Happened? A number of stocks fell in the afternoon session after the renewed Iran-UAE incident reignited concerns about input cost inflation and global ...
Healthcare company Baxter International (NYSE:BAX) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 2.9% year on year to...
Healthcare company Baxter International (NYSE:BAX) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 2.9% year on year to $2.7...
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results this Thursday before market hours. Here’s what to look for. Baxter bea...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...
The medical technology landscape witnessed a seismic shift on Tuesday as Avanos Medical (NYSE: AVNS) announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an all-cash transaction valued at approximately $1.27 billion. The deal marks a significant turning point
Baxter International Inc. (NYSE:BAX), a global medtech leader, is highlighting recent additions to its Global Surgical Solutions and Patient Support Systems portfolios, as well as its broad Advanced Surgery portfolio of hemostatic and sealing agents, at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo, taking place April 11-14, 2026 in New Orleans. New offerings include the AAT XR spine surgical table and the Dynamo Series smart stretcher, both on display at Baxter booth #1319.
